Article
TNF-α Promoter Polymorphisms Predict the Response to Etanercept More Powerfully than that to Infliximab/Adalimumab in Spondyloarthritis.
Scientific reports - 31 Aug 2016
Liu Jing, Dong Zheng, Zhu Qi, He Dongyi, Ma Yanyun, Du Aiping, He Fan, Zhao Dongbao, Xu Xia, Zhang Hui, Jin Li, Wang Jiucun
Abstract excerpt
While previous studies have researched in association analyses between TNFα promoter polymorphisms and responses to TNF blockers in spondyloarthritis patients, their results were conflicting. Therefore, we aimed to determine whether TNFα promoter polymorphisms could predict response to TNF blockers and find the source of heterogeneity. Data were extracted and analyzed from published articles and combined with our...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
